Cargando…

Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography

BACKGROUND: Antiangiogenesis is a promising therapy for advanced hepatocellular carcinoma (HCC), but the effects are difficult to be evaluated. Pazopanib (GW786034B) is a pan-vascular endothelial growth factor receptor inhibitor, the antitumor effects or antiangiogenic effects haven't been inve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Xiao-Dong, Zhang, Ju-Bo, Fan, Pei-Li, Xiong, Yu-Quan, Zhuang, Peng-Yuan, Zhang, Wei, Xu, Hua-Xiang, Gao, Dong-Mei, Kong, Ling-Qun, Wang, Lu, Wu, Wei-Zhong, Tang, Zhao-You, Ding, Hong, Sun, Hui-Chuan
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033852/ https://www.ncbi.nlm.nih.gov/pubmed/21251271 http://dx.doi.org/10.1186/1471-2407-11-28

Ejemplares similares

Relationship between quantitative contrast-enhanced ultrasonography parameters and angiogenesis in primary small hepatocellular carcinoma: A retrospective study
por: Deng, Shuhao, et al.
Publicado: (2021)

Early detection of antiangiogenic treatment responses in a mouse xenograft tumor model using quantitative perfusion MRI
por: Rajendran, Reshmi, et al.
Publicado: (2014)

Contrast-Enhanced Ultrasonography with Quantitative Analysis allows Differentiation of Renal Tumor Histotypes
por: Sun, Di, et al.
Publicado: (2016)

Lack of Efficacy of Combined Antiangiogenic Therapies in Xenografted Human Melanoma
por: Adamcic, Una, et al.
Publicado: (2012)

Shear wave elastography and contrast-enhanced ultrasonography in the diagnosis of thyroid malignant nodules
por: Chen, Mei, et al.
Publicado: (2016)

Oral Side Effects in Patients with Metastatic Renal Cell Carcinoma Receiving the Antiangiogenic Agent Pazopanib—Report of Three Cases
por: Papadopoulou, Erofili, et al.
Publicado: (2022)

Additive Antiproliferative and Antiangiogenic Effects of Metformin and Pemetrexed in a Non-Small-Cell Lung Cancer Xenograft Model
por: Wang, Jiun-Long, et al.
Publicado: (2021)

Antitumor and Antiangiogenic Activities of Curcumin in Cervical Cancer Xenografts in Nude Mice
por: Yoysungnoen-Chintana, Pornphrom, et al.
Publicado: (2014)

Pretreatment Evaluation with Contrast-Enhanced Ultrasonography for Percutaneous Radiofrequency Ablation of Hepatocellular Carcinomas with Poor Conspicuity on Conventional Ultrasonography
por: Kim, Ah Yeong, et al.
Publicado: (2013)

Sonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma: strengths and shortcomings
por: Lee, Sung Won, et al.
Publicado: (2023)

Usefulness of contrast-enhanced ultrasonography in the diagnosis of ruptured hepatocellular carcinoma
por: Shiozawa, Kazue, et al.
Publicado: (2013)

Evaluation of Antiangiogenic Effects of a New Synthetic Candidate Drug KR-31831 on Xenografted Ovarian Carcinoma Using Dynamic Contrast Enhanced MRI
por: Yang, Jehoon, et al.
Publicado: (2011)

Quantitative Assessment of Tissue Perfusion in Hepatocellular Carcinoma Using Perflubutane Dynamic Contrast-Enhanced Ultrasonography: A Preliminary Study
por: Ohno, Naoki, et al.
Publicado: (2015)

Dynamic Contrast-Enhanced MRI for Monitoring Antiangiogenic Treatment: Determination of Accurate and Reliable Perfusion Parameters in a Longitudinal Study of a Mouse Xenograft Model
por: Song, Youngkyu, et al.
Publicado: (2013)

Accurate ultrasonography-based portal pressure assessment in patients with hepatocellular carcinoma
por: Zhang, Yu, et al.
Publicado: (2020)

Quantitative Evaluation of Contrast-Enhanced Ultrasonography in the Diagnosis of Chronic Ischemic Renal Disease in a Dog Model
por: Dong, Yi, et al.
Publicado: (2013)

Loco-regional treatment of hepatocellular carcinoma: Role of contrast-enhanced ultrasonography
por: Inzerillo, Agostino, et al.
Publicado: (2022)

Quantitative analysis of contrast-enhanced ultrasonography in acute radiation-induced liver injury: An animal model
por: FENG, JUN, et al.
Publicado: (2015)

Application of quantitative analysis of contrast-enhanced ultrasonography in the evaluation of acute radiation-induced liver damage
por: Xin, Tian-You, et al.
Publicado: (2020)

Quantitative phosphoproteomic analysis of acquired cancer drug resistance to pazopanib and dasatinib
por: Vyse, Simon, et al.
Publicado: (2018)

Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety
por: Welker, Martin-Walter, et al.
Publicado: (2013)

Contrast-enhanced endoscopic ultrasonography: advance and current status
por: Jang, Sung Ill, et al.
Publicado: (2014)

Quantitative analysis of contrast-enhanced ultrasonography in rat models of hepatic acute graft-versus-host disease
por: Xin, Yuwei, et al.
Publicado: (2023)

Quantitative contrast-enhanced ultrasonography for the differential diagnosis of endometrial hyperplasia and endometrial neoplasms
por: Liu, Ying, et al.
Publicado: (2016)

Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma
por: Park, Kil Hyo, et al.
Publicado: (2015)

Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy
por: Ebos, John ML, et al.
Publicado: (2014)

Pazopanib, a Receptor Tyrosine Kinase Inhibitor, Suppresses Tumor Growth through Angiogenesis in Dedifferentiated Liposarcoma Xenograft Models()()()
por: Li, Haifu, et al.
Publicado: (2014)

Role of antiangiogenic agents in first-line treatment for advanced NSCLC in the era of immunotherapy
por: Pang, Lan-Lan, et al.
Publicado: (2023)

Contrast-enhanced ultrasonography for differential diagnosis of adnexal masses
por: Shentu, Weihui, et al.
Publicado: (2022)

Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells
por: Di Desidero, Teresa, et al.
Publicado: (2019)

Contrast-enhanced ultrasonography of the carotids
por: Rafailidis, Vasileios, et al.
Publicado: (2015)

Combination Antiangiogenic and Immunotherapy for Advanced Hepatocellular Carcinoma: Evidence to Date
por: Raybould, Alison L, et al.
Publicado: (2020)

LI-RADS ancillary features on contrast-enhanced ultrasonography
por: Dietrich, Christoph F., et al.
Publicado: (2020)

Qualitative and Quantitative Analysis with Contrast-Enhanced Ultrasonography: Diagnosis Value in Hypoechoic Renal Angiomyolipoma
por: Lu, Qing, et al.
Publicado: (2015)

Repeatability and reproducibility of quantitative contrast-enhanced ultrasonography for assessing duodenal perfusion in healthy dogs
por: NISA, Khoirun, et al.
Publicado: (2017)

Local ablation therapy with contrast-enhanced ultrasonography for hepatocellular carcinoma: a practical review
por: Kim, Tae Kyoung, et al.
Publicado: (2015)

Temozolomide and Pazopanib Combined with FOLFOX Regressed a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse Model
por: Zhu, Guangwei, et al.
Publicado: (2020)

Up-regulation of platelet-derived growth factor-A is responsible for the failure of re-initiated interferon alpha treatment in hepatocellular carcinoma
por: Zhang, Ju-Bo, et al.
Publicado: (2012)

Pazopanib and anti-VEGF therapy
por: Drabkin, Harry A
Publicado: (2010)

Pazopanib and Statin-Induced Rhabdomyolysis
por: Logue, Jennifer M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ntjippfufgklu9vvvhomacb0u9